Stock Markets May 13, 2026 08:18 PM

Federal Judge Halts DOJ Demand for Rhode Island Hospital Records on Youth Gender Care

Judge Mary McElroy finds prosecutors misled the court and blocks broad subpoena for minors' medical records

By Derek Hwang

A U.S. district judge has barred the Justice Department from compelling Rhode Island Hospital to surrender extensive records related to gender-affirming treatment for transgender minors, finding prosecutors acted in bad faith and that compliance would violate patient privacy. The decision interrupts a wider federal effort to probe such care for youths and follows a Texas court order that had attempted to force compliance.

Federal Judge Halts DOJ Demand for Rhode Island Hospital Records on Youth Gender Care

Key Points

  • A federal judge blocked the Justice Department from enforcing a broad subpoena on Rhode Island Hospital seeking records related to gender-affirming care for minors.
  • Judge Mary McElroy found prosecutors acted in bad faith and said enforcing the subpoena would violate the privacy rights of minor patients; she also criticized DOJ tactics in court filings.
  • The action is part of a wider federal push to investigate gender-affirming care for minors, including similar subpoenas to other providers and a shift of some probes to northern Texas.

A federal judge in Rhode Island has blocked the Justice Department from enforcing a sweeping subpoena that sought broad categories of records from Rhode Island Hospital concerning gender-affirming care for transgender minors. In a written order issued Wednesday, District Judge Mary McElroy concluded prosecutors had acted in bad faith and that compelling the hospital to turn over the material would infringe on the privacy rights of minor patients.

The subpoena, issued to the hospital operated by Brown Health, requested a wide array of documents, including medical records of minors treated for gender dysphoria with medications such as puberty blockers. Rhode Island Hospital and the state's child advocate petitioned the court to intervene before a Thursday compliance deadline after a judge in Texas - at the request of the Justice Department - had ordered the hospital to produce the requested materials.

McElroy rejected the Justice Department's representation that its inquiry was focused on alleged off-label use of drugs that are approved by the U.S. Food and Drug Administration. She determined that forcing the hospital to comply would run afoul of privacy protections for minor patients and was not justified by the government's stated investigative purpose.

“DOJ has proven unworthy of this trust at every point in this case,” McElroy wrote. She added that "the discrepancy between the honorable conduct expected of federal prosecutors and DOJs tactics in this case is unsettling."

The dispute is one element of a broader federal initiative to scrutinize gender-affirming care for minors. According to the court record, the Justice Department has issued similar subpoenas to multiple healthcare providers; some of those demands have been narrowed or quashed by other courts.

Last year, President Donald Trump signed an executive order ending federal funding or support for gender-affirming care for transgender youth and described such care as a "dangerous trend." That order also directed the Justice Department to prioritize investigations into these treatments. LGBT rights organizations and leading medical associations, as referenced in the filings, support gender-affirming therapies as important to the well-being of transgender youth.

Following judicial setbacks in various forums, the Justice Department shifted certain parts of its investigative activity to northern Texas, a tactic Judge McElroy characterized as forum shopping. A judge in Texas had previously ordered Rhode Island Hospital to comply with the subpoena sought by federal prosecutors.

In a related development, federal prosecutors in Texas issued a grand jury subpoena this week to NYU Langone Health seeking information on gender-affirming care for minors, the filings indicate. That move came shortly before McElroy's decision blocking compliance by the Rhode Island institution.


Because the court found the Justice Department had misrepresented aspects of its investigation and had pursued the subpoena in a way that risked violating patient privacy, McElroy's order prevents enforcement of the demand while the legal fight continues.

Risks

  • Potential continued litigation over similar subpoenas could create legal uncertainty for hospitals and providers involved in pediatric gender-affirming care - impacts the healthcare sector and hospital providers.
  • Forum-shopping and inter-jurisdictional disputes may lead to inconsistent court rulings and further legal costs for institutions responding to federal investigations - impacts legal services and health system compliance functions.
  • Ongoing federal scrutiny and executive directives could influence funding, compliance demands, and institutional policies related to gender-affirming services for minors - impacts hospital operations and pediatric care programs.

More from Stock Markets

Bain and LY Raise Offer for Kakaku as EQT Moves in With Competing Bid May 13, 2026 EagleRock Raises $320.1 Million in U.S. IPO, Lists as EROK Amid Permian Asset Play May 13, 2026 Cohen Intensifies Hostile Push After eBay Rebuffs $125-a-Share Offer May 13, 2026 Micware Prices Upsized IPO at $8.00 Per ADS, Plans Nasdaq Listing May 13, 2026 EagleRock Prices IPO at $18.50 a Share, Anticipates $286.6 Million in Net Proceeds May 13, 2026